IL1A and cancer: The interleukin 1 (IL-1) family, long recognized for its pleiotropic effects on inflammation, plays a complex, sometimes contradictory role in different stages of cancer development, there are numerous ligands and receptors in this family; however, IL-1α and IL-1β are the two main agonists [15,16].